A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
